GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moolec Science SA (NAS:MLEC) » Definitions » EBITDA Margin %

Moolec Science (Moolec Science) EBITDA Margin % : -660.71% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Moolec Science EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Moolec Science's EBITDA for the three months ended in Dec. 2023 was $-1.67 Mil. Moolec Science's Revenue for the three months ended in Dec. 2023 was $0.25 Mil. Therefore, Moolec Science's EBITDA margin for the quarter that ended in Dec. 2023 was -660.71%.


Moolec Science EBITDA Margin % Historical Data

The historical data trend for Moolec Science's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moolec Science EBITDA Margin % Chart

Moolec Science Annual Data
Trend Jun21 Jun22 Jun23
EBITDA Margin %
- - -5,717.24

Moolec Science Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -323.98 -87.13 -660.71

Competitive Comparison of Moolec Science's EBITDA Margin %

For the Biotechnology subindustry, Moolec Science's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moolec Science's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moolec Science's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Moolec Science's EBITDA Margin % falls into.



Moolec Science EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Moolec Science's EBITDA Margin % for the fiscal year that ended in Jun. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2023 )/Revenue (A: Jun. 2023 )
=-51.741/0.905
=-5,717.24 %

Moolec Science's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-1.665/0.252
=-660.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Moolec Science  (NAS:MLEC) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Moolec Science EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Moolec Science's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Moolec Science (Moolec Science) Business Description

Traded in Other Exchanges
N/A
Address
17, Boulevard F.W. Raiffeisen, Luxembourg, LUX, L-2411
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system.